On September 15, Taienkang Started IPO “Initial Public Offerings”. Over the past 20 years, Taienkang has actively explored the innovation of marketing business models, and has become a comprehensive pharmaceutical enterprise integrating research, production and sales. It has continuously increased its efforts in production and research and development, and improved the core technology of products through innovative production processes.

In the future, Taienkang will always adhere to the corporate philosophy of "Honesty, Enterprise, Sincerity", insist on taking public health as its own responsibility, and take innovation and research and development as its core development. And improve the company’s product system, quickly realize the large-scale production of products through the company’s technology industrialization platform and pharmaceutical production base, enhance the core competitiveness of the market, cooperate with partners for a win-win situation, create public welfare value for the society, bring healthy products to customers, and serve Work hard for the big cause of health.